If you care about the future of genomics, diagnostics, and biotech investing, you can’t miss this episode.

We’re joined by Mara Aspinall, Partner at Illumina Ventures, a trailblazer with over 30 years of leadership in diagnostics and eight years in venture capital funding groundbreaking genomics companies.

In this episode, Mara reveals:

• The next wave of diagnostics, from liquid biopsies to home testing and new AI-driven tools.
• Hard-won lessons from leading Genzyme Genetics, Roche Tissue Diagnostics, and building her own startup.
• Insider tips for founders on pitching, choosing the right investors, and building winning teams.
• A glimpse into where genomics is heading in the next decade - from neurodegenerative disease detection to early metabolic disease diagnostics.

With her unmatched experience as an operator, educator, and investor, Mara brings clarity, energy, and vision to a fast-changing field. This conversation is packed with takeaways for founders, investors, and anyone fascinated by the future of healthcare.

🎧 Tune in now for a masterclass in diagnostics, genomics, and venture capital from one of the industry’s most influential voices.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: Leading Beyond The Lab

Instagram: Instagram (@arto.talent)

TikTok: artotalent on TikTok

Apple Podcasts: Leading Beyond The Lab

Website: Home

Youtube: ARTO Recruitment

Mara Aspinall

Partner At Illumina Ventures

LinkedIn: https://www.linkedin.com/in/mara-aspinall-6688142/

Lawrence Rose

Co-Founder + Talent Solutions Director At ARTO

LinkedIn: https://www.linkedin.com/in/lawrencerose/

Timestamps:

00:00 Career Beginnings

04:10 Current Diagnostic Trends

20:48 The Founder Investor Fit

25:37 Genetics & Genomics

29:06 Mara Aspinall

39:31 Neurodegenerative Disease

#LeadingBeyondTheLab #ARTOTalent #Biotechnology 

Hosted on Acast. See acast.com/privacy for more information.